✦ LIBER ✦

Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice

✍ Scribed by K. Yamaki; S. Yoshino

Book ID: 110887479
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 586 KB
Volume: 67
Category: Article
ISSN: 0105-4538
DOI: 10.1111/j.1398-9995.2011.02717.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic efficacy of Sunitinib and ot

Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis

✍ Knoerzer, D; Baginski, T; Wade, K; Fan, C; Rapp, S; Regina, K; Shih, F; Burney, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 70 KB

70 AN ORAL SMALL-MOLECULE MULTITARGETED

70 AN ORAL SMALL-MOLECULE MULTITARGETED RECEPTOR TYROSINE KINASE INHIBITOR, SUNITINIB, DEMONSTRATES GROWTH INHIBITION IN BONE METASTASIS OF RENAL CELL CANCER IN VIVO

✍ Maita, Shinya; Yuasa, Takeshi; Tsuchiya, Norihiko; Mitobe, Yoko; Narita, Shintar 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Pretreatment of Rho Kinase Inhibitor Inh

Pretreatment of Rho Kinase Inhibitor Inhibits Systemic Inflammation and Prevents Endotoxin-Induced Acute Lung Injury in Mice

✍ Ren Yu Ding; Dong Mei Zhao; Zhi Dan Zhang; Ren Xuan Guo; Xiao Chun Ma 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 824 KB

Oral small-molecule tyrosine kinase inhi

Oral small-molecule tyrosine kinase inhibitor midostaurin (PKC412) inhibits growth and induces megakaryocytic differentiation in human leukemia cells

✍ Yu-Chuen Huang; David K. Chao; K.S. Clifford Chao; Yu-Jen Chen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 853 KB

Systemic Antiamebic Antibodies Induced O

Systemic Antiamebic Antibodies Induced Orally in Mice: Detection by an ELISA Test Using Preserved Entamoeba histolytica-Antigens Without Enzymatic Inhibitors

✍ E Tamez-Treviño; J Sepúlveda-Saavedra; R Tijerina-Menchaca; M.S Flores-Castañeda 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 50 KB

The orally-active and selective c-Fms ty

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model

✍ Hiroaki Ohno; Yasunori Uemura; Hideko Murooka; Hiromi Takanashi; Takemi Tokieda; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB